NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 922 filers reported holding NOVARTIS A G in Q2 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $576,000 | -13.8% | 6,900 | -23.3% | 0.00% | 0.0% |
Q1 2017 | $668,000 | +1.8% | 9,000 | 0.0% | 0.00% | -33.3% |
Q4 2016 | $656,000 | -4.5% | 9,000 | +3.4% | 0.00% | +50.0% |
Q3 2016 | $687,000 | -13.3% | 8,700 | -9.4% | 0.00% | -33.3% |
Q2 2016 | $792,000 | +14.0% | 9,600 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $695,000 | -15.6% | 9,600 | +7.9% | 0.00% | 0.0% |
Q4 2015 | $823,000 | +0.6% | 8,900 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $818,000 | -6.5% | 8,900 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $875,000 | +13.8% | 8,900 | +14.1% | 0.00% | +50.0% |
Q1 2015 | $769,000 | +6.4% | 7,800 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $723,000 | -1.5% | 7,800 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $734,000 | -6.9% | 7,800 | -10.3% | 0.00% | 0.0% |
Q2 2014 | $788,000 | +6.5% | 8,700 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $740,000 | +5.9% | 8,700 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $699,000 | +4.8% | 8,700 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $667,000 | +8.5% | 8,700 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $615,000 | – | 8,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
Elefante Mark B | 4,579 | $333,000 | 4.02% |
COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |